Director & Chief Executive Officer
Director & Chief Executive Officer at Inhibrx Biosciences, Inc., filing insider transactions between 2026-09-08 and 2026-10-14.
| SEC ↗ |
| 2026-10-14 | INBX | Purchase | 2,449 | $84.07 | $206K | SEC ↗ |
| 2026-10-14 | INBX | Purchase | 2,451 | $85.00 | $208K | SEC ↗ |
| 2026-09-28 | INBX | Purchase | 1,500 | $98.88 | $148K | SEC ↗ |
| 2026-09-28 | INBX | Purchase | 3,000 | $101.70 | $305K | SEC ↗ |
| 2026-09-25 | INBX | Purchase | 3,324 | $98.87 | $329K | SEC ↗ |
| 2026-09-25 | INBX | Purchase | 2,176 | $99.60 | $217K | SEC ↗ |
| 2026-09-08 | INBX | Purchase | 5,895 | $99.29 | $585K | SEC ↗ |
| 2026-09-08 | INBX | Purchase | 6,605 | $100.64 | $665K | SEC ↗ |
| 2026-09-08 | INBX | Purchase | 1,100 | $107.12 | $118K | SEC ↗ |
| 2026-09-08 | INBX | Purchase | 500 | $108.23 | $54K | SEC ↗ |
| 2026-09-08 | INBX | Purchase | 1,219 | $111.88 | $136K | SEC ↗ |
| 2026-09-08 | INBX | Purchase | 9,681 | $112.28 | $1.1M | SEC ↗ |